EZH1/2 Inhibitors Favor ILC3 Development from Human HSPC-CD34(+) Cells

SIMPLE SUMMARY: It has been well-demonstrated that EZH1/2 enzymes are involved not only in tumor development and progression, but also in the regulation of normal hematopoiesis from CD34(+)-HSPC. Given the crucial role of NK cells in tumor immune surveillance, in this study, we investigated whether...

Descripción completa

Detalles Bibliográficos
Autores principales: Damele, Laura, Amaro, Adriana, Serio, Alberto, Luchetti, Silvia, Pfeffer, Ulrich, Mingari, Maria Cristina, Vitale, Chiara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830003/
https://www.ncbi.nlm.nih.gov/pubmed/33467134
http://dx.doi.org/10.3390/cancers13020319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830003/
https://www.ncbi.nlm.nih.gov/pubmed/33467134
http://dx.doi.org/10.3390/cancers13020319

Ejemplares similares